bromocriptine has been researched along with tamoxifen in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (70.37) | 18.7374 |
| 1990's | 11 (20.37) | 18.2507 |
| 2000's | 3 (5.56) | 29.6817 |
| 2010's | 2 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Limb, DG | 1 |
| Ward, HW | 1 |
| Gateley, CA; Mansel, RE | 1 |
| Bergström, M; Muhr, C | 1 |
| Avril-Ducarne, C; Bastit, P; Bisson, JP; Cossec, A; Kuhn, JM; Wolf, LM | 1 |
| Bonneterre, J; Cappelaere, P; Chollet, P; Fargeot, P; Mauriac, L; Roche, H; Sevin, M; Tubiana-Hulin, M; Weber, B | 1 |
| Ip, C; Ip, MM; Sylvester, PW | 1 |
| Angeli, A; Dogliotti, L; Fioretti, P; Melis, GB; Mussa, A | 1 |
| Aono, T; Koizumi, K | 1 |
| Bavli, IaL; Moiseenko, VM; Semiglazov, VF | 1 |
| Farabegoli, G; Martoni, A; Pannuti, F; Piana, E | 1 |
| Scott, EB | 1 |
| Mainenti, M; Silvestre, V; Zacché, G; Zanoio, L | 1 |
| Muldoon, TG | 1 |
| Crosignani, PG; Ferrari, C | 1 |
| Hofland, L; Lamberts, SW; Oosterom, R; Verleun, T | 1 |
| Fukushima, T; Hirakawa, T; Kibe, M; Matsuda, T; Tashiro, Y; Tomonaga, M; Yamashita, M | 1 |
| Ip, MM; Sylvester, PW | 1 |
| Lamberts, SW | 1 |
| Fujimoto, N; Ito, A; Kawashima, K; Naito, M; Watanabe, H | 1 |
| Bartsch, G; Oberholzer, M; Rohr, HP | 1 |
| Hauri, D; Schoenenberger, A | 1 |
| Bartsch, G; Daxenbichler, G; Rohr, HP | 1 |
| Hayward, JL | 1 |
| Arafah, BM; Finegan, HM; Manni, A; Pearson, OH; Rainieri, J | 1 |
| Imura, H; Kato, Y; Matsushita, N; Waseda, N | 1 |
| DeHoog, JV; Welsch, CW | 1 |
| Aylsworth, CF; Meites, J; Sylvester, PW; Van Vugt, DA | 1 |
| Arafah, BM; Brodkey, JS; Pearson, OH; Rainieri, J; Wilhite, BL | 1 |
| Collins, DC; Lyle, SF; Wright, K | 1 |
| de Quijada, M; Lamberts, SW; MacLeod, RM; Timmermans, HA | 1 |
| Brown, CK; Goodrich-Smith, M; Johnson, D; Mackie, D; Welsch, CW | 1 |
| Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ | 1 |
| Edwards, JN | 1 |
| Gehring, WG; Schneider, J; Völker, W; von zur Mühlen, A | 1 |
| Gnatyshak, AI | 1 |
| Lamberts, SW; Oosterom, R; Verleun, T | 1 |
| Berning, R; Gehring, WG; Schmidt, RC; Schneider, J; Völker, W; von zur Mühlen, A | 1 |
| Adam, HK; Kemp, JV; Patterson, JS; Settatree, RS | 1 |
| MacLeod, RM; Nagy, I; Valdenegro, CA | 1 |
| de Quijada, M; Lamberts, SW; Timmermans, HA | 1 |
| Buscarini, M; D'Eramo, G; Di Silverio, F; Flammia, GP; Frascaro, E; Mariani, M; Sciarra, A | 1 |
| BeLieu, RM | 1 |
| Barbosa-Coutinho, LM; Cericatto, R; Dahlem, N; Oliveira, MC; Pavanato, MA; Ribeiro, MF; Silva, IS; Spritzer, PM | 1 |
| Aguilar, R; Gaytán, F; Ruiz, A; Sánchez-Criado, JE; Tébar, AM | 1 |
| Andrade, N; Bergoc, R; Caro, R; Cricco, G; Davio, C; Martin, G; Melito, G; Rivera, E | 1 |
| Rodriguez, JL; Steinbrunn, BS; Zera, RT | 1 |
| Ahn, BT; Baik, SH; Lee, BL; Lee, SY | 1 |
| Faiz, O; Fentiman, IS | 1 |
| Arvind, N; Chabra, A; Dhar, A; Mansel, RE; Prasad, K; Srivastava, A | 1 |
13 review(s) available for bromocriptine and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Positron emission tomography applied in the study of pituitary adenomas.
Topics: Adenoma; Amino Acids; Animals; Bromocriptine; Dopamine Antagonists; Humans; Macaca mulatta; Methionine; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography; Receptors, Dopamine; Receptors, Dopamine D2; Tamoxifen; Tomography, Emission-Computed | 1991 |
Fibrocystic breast disease.
Topics: Adult; Breast; Bromocriptine; Danazol; Female; Fibrocystic Breast Disease; Humans; Mammography; Middle Aged; Nutritional Physiological Phenomena; Palpation; Tamoxifen | 1987 |
[Update in the therapy of fibrocystic mastopathy].
Topics: Bromocriptine; Danazol; Endocrine System Diseases; Female; Fibrocystic Breast Disease; Humans; Pregnadienes; Progestins; Tamoxifen | 1987 |
Steroid hormone receptor regulation by various hormonal factors during mammary development and growth in the normal mouse.
Topics: Animals; Bromocriptine; Cell Nucleus; Cellulose; Cytosol; Diethylstilbestrol; DNA; Estradiol; Estrogens; Female; Hot Temperature; Kinetics; Mammary Glands, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Ovariectomy; Pregnancy; Prolactin; Receptors, Estrogen; Receptors, Progesterone; Species Specificity; Substrate Specificity; Tamoxifen; Thyroidectomy; Uterus | 1986 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
[Conservative treatment of benign prostatic hyperplasia (author's transl)].
Topics: Adrenergic alpha-Antagonists; Bromocriptine; Cyproterone; Gestonorone Caproate; Humans; Male; Medrogestone; Megestrol; Plant Extracts; Polyenes; Prostatic Hyperplasia; Spironolactone; Tamoxifen | 1982 |
[Antiestrogens in the treatment of breast cancer].
Topics: Adult; Blood Proteins; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Estrogen Antagonists; Female; Homeostasis; Humans; Levodopa; Ligands; Male; Menopause; Middle Aged; Tamoxifen | 1981 |
[Pharmacological combinations in the treatment of benign prostatic hypertrophy].
Topics: Bromocriptine; Cyproterone Acetate; Drug Therapy, Combination; Gestonorone Caproate; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Tamoxifen | 1993 |
Mastodynia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Diseases; Bromocriptine; Diet; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Gonadotropin-Releasing Hormone; Humans; Linoleic Acids; Oenothera biennis; Pain; Pain Management; Plant Oils; Prevalence; Risk Factors; Tamoxifen; Treatment Outcome | 1994 |
Mastalgia. Tailoring treatment to type of breast pain.
Topics: Breast; Breast Neoplasms; Bromocriptine; Danazol; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Hormone Antagonists; Humans; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Risk Factors; Tamoxifen | 1997 |
Management of breast pain.
Topics: Breast Diseases; Bromocriptine; Danazol; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Pain; Progesterone; Tamoxifen | 2000 |
Evidence-based management of Mastalgia: a meta-analysis of randomised trials.
Topics: Breast Diseases; Bromocriptine; Danazol; Estrogen Antagonists; Female; Humans; Pain; Pain Measurement; Phytotherapy; Plant Oils; Primula; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2007 |
4 trial(s) available for bromocriptine and tamoxifen
| Article | Year |
|---|---|
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting | 1977 |
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Double-Blind Method; Female; Humans; Multicenter Studies as Topic; Tamoxifen | 1988 |
[Adjuvant therapy of breast cancer patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Random Allocation; Tamoxifen; Thiotepa | 1986 |
[Pharmacological combinations in the treatment of benign prostatic hypertrophy].
Topics: Bromocriptine; Cyproterone Acetate; Drug Therapy, Combination; Gestonorone Caproate; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Tamoxifen | 1993 |
38 other study(ies) available for bromocriptine and tamoxifen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The management of anovulatory infertility.
Topics: Anovulation; Bromocriptine; Clomiphene; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Tamoxifen | 1978 |
Cyclical breast pain--what works and what doesn't.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Diseases; Bromocriptine; Danazol; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Goserelin; Humans; Linoleic Acids; Oenothera biennis; Pain; Periodicity; Plant Oils; Premenstrual Syndrome; Tamoxifen | 1992 |
Management of the painful and nodular breast.
Topics: Adult; Age Factors; Breast Diseases; Bromocriptine; Buserelin; Danazol; Estrogen Replacement Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Goserelin; Humans; Hypolipidemic Agents; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Tamoxifen | 1991 |
[A hormone assay as a therapeutic choice in male sterility].
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hyperprolactinemia; Hypogonadism; Infertility, Male; Luteinizing Hormone; Male; Menotropins; Prolactin; Sperm Count; Tamoxifen; Testosterone | 1990 |
Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Dietary Fats; Estrogens; Female; Mammary Neoplasms, Experimental; Ovariectomy; Ovary; Prolactin; Rats; Tamoxifen | 1986 |
Current status of hormonal therapy of fibrocystic breast disease.
Topics: Bromocriptine; Chronobiology Phenomena; Danazol; Female; Fibrocystic Breast Disease; Humans; Lynestrenol; Pregnadienes; Prolactin; Sulpiride; Tamoxifen; Thermography; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1986 |
Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
Topics: Adult; Animals; Bromocriptine; Callitrichinae; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Rabbits; Rats; Tamoxifen | 1986 |
Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Delayed-Action Preparations; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin; Tamoxifen; Testosterone; Thyroid Hormones | 1985 |
Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
Topics: Aged; Aged, 80 and over; Bromocriptine; Cells, Cultured; Dopamine; Estradiol; Female; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tamoxifen | 1986 |
[Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
Topics: Adenoma; Adenoma, Chromophobe; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tamoxifen | 1987 |
Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bromocriptine; Cell Line; Drug Therapy, Combination; Haloperidol; Male; Neoplasm Transplantation; Orchiectomy; Prolactin; Prostatic Neoplasms; Rats; Tamoxifen; Testosterone | 1987 |
Interactions of steroids with prolactin secretion in vitro.
Topics: Bromocriptine; Cells, Cultured; Dopamine; Estradiol; Humans; Kinetics; Pituitary Gland; Pituitary Neoplasms; Prolactin; Steroids; Tamoxifen | 1985 |
Inhibition by 2-bromo-alpha-ergocriptine and tamoxifen of the growth of an estrogen-dependent transplantable pituitary tumor (MtT/F84) in F344 rats.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Estradiol; Female; Neoplasm Transplantation; Pituitary Neoplasms; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Estrogen; Tamoxifen | 1985 |
The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
Topics: Aged; Bromocriptine; Cyproterone; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Prolactin; Prostate; Prostatic Hyperplasia; Tamoxifen; Testosterone | 1981 |
4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
Topics: Androgen Antagonists; Bromocriptine; Cyproterone; Cyproterone Acetate; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Muscle, Smooth; Prolactin; Prostate; Prostatic Hyperplasia; Tamoxifen; Testosterone | 1983 |
The changing role of endocrine therapy in the management of advanced breast cancer.
Topics: Adrenal Glands; Aminoglutethimide; Breast Neoplasms; Bromocriptine; Female; Hormones; Humans; Pituitary Gland; Receptors, Cell Surface; Tamoxifen | 1980 |
Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Topics: Animals; Bromocriptine; Castration; Estradiol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Perphenazine; Prolactin; Rats; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Prolactin; Tamoxifen | 1982 |
Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Receptors, Prolactin; Tamoxifen | 1983 |
Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Bromocriptine; Cell Division; Diterpenes; Female; Kinetics; Mammary Neoplasms, Experimental; Mycobacterium bovis; Nocardia; Rats; Retinyl Esters; Tamoxifen; Vitamin A | 1983 |
Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Castration; Estradiol; Female; Haloperidol; Mammary Neoplasms, Experimental; Ovary; Rats; Rats, Inbred Strains; Tamoxifen | 1983 |
Inhibitory action of bromocriptine and tamoxifen on the growth of human pituitary tumors in soft agar.
Topics: Adenoma; Agar; Bromocriptine; Cells, Cultured; Clone Cells; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Tamoxifen | 1983 |
Comparative effects of tamoxifen and bromocriptine on prolactin and pituitary weight in estradiol-treated male rats.
Topics: Animals; Bromocriptine; Estradiol; Estrogen Antagonists; Hyperplasia; Male; Organ Size; Pituitary Gland; Prolactin; Rats; Rats, Inbred ACI; Tamoxifen; Time Factors | 1984 |
Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
Topics: Animals; Bromocriptine; Dopamine; Estradiol; Female; Haloperidol; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Tamoxifen; Thyrotropin-Releasing Hormone | 1980 |
2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Rats; Rats, Inbred Strains; Tamoxifen; Time Factors | 1982 |
Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
Topics: Animals; Bromocriptine; Castration; Cells, Cultured; DNA, Neoplasm; Female; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Tamoxifen | 1983 |
Infertility treatment. An approach for the general practitioner.
Topics: Bromocriptine; Clomiphene; Female; Humans; Infertility, Female; Infertility, Male; Male; Physician's Role; Physicians, Family; Tamoxifen | 1983 |
[Bromocriptine and tamoxifen--a new therapeutic approach in suppression-resistant prolactin-secreting adenomas].
Topics: Adolescent; Adult; Bromocriptine; Drug Therapy, Combination; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Tamoxifen | 1982 |
Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
Topics: Adenoma; Adult; Bromocriptine; Drug Interactions; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tamoxifen | 1982 |
Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen.
Topics: Adenoma, Chromophobe; Adolescent; Adult; Bromocriptine; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tamoxifen | 1982 |
Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.
Topics: Breast Neoplasms; Bromocriptine; Drug Therapy, Combination; Estradiol; Female; Half-Life; Humans; Hydrocortisone; Middle Aged; Tamoxifen | 1980 |
Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats.
Topics: Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Rats; Tamoxifen; Transplantation, Homologous | 1980 |
Tamoxifen suppresses both the growth of prolactin-secreting pituitary tumours and normal prolactin synthesis in the rat.
Topics: Animals; Bromocriptine; Depression, Chemical; Female; In Vitro Techniques; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Tamoxifen | 1980 |
Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
Topics: Animals; Bromocriptine; Cell Count; DNA; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Hormone Antagonists; Immunohistochemistry; Organ Size; Ovariectomy; Pituitary Gland; Prolactin; Radioimmunoassay; Rats; Rats, Wistar; Tamoxifen; Uterus | 1996 |
RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
Topics: Androgen Antagonists; Animals; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Estrogen Antagonists; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Progesterone; Rats; Rats, Wistar; Tamoxifen | 1996 |
Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.
Topics: Animals; Bromocriptine; Carcinogens; Estradiol; Female; Haloperidol; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Tamoxifen | 1997 |
Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Bromocriptine; Cell Count; Cell Division; Dopamine Agonists; Estradiol; Humans; Microscopy, Electron; Neoplasms, Radiation-Induced; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine; Tamoxifen; Tumor Cells, Cultured | 1998 |